SUMMARY Antibodies reacting with a human liver-specific membrane lipoprotein (LSP) The timing of the anti-LSP response makes it very unlikely that it is involved in the pathogenesis of the early bile duct damage but the results of this and other studies suggest that antibodies to this hepatocyte membrane lipoprotein may be an important cause of periportal liver cell necrosis in both primary biliary cirrhosis and chronic active hepatitis and could be one of the factors determining progression to cirrhosis in both these conditions.
The earliest histological lesion in primary biliary cirrhosis consists of a lymphocytic and plasma cell infiltrate with granuloma formation often associated with damaged interlobular bile ducts.' Although these appearances are suggestive of an intense inflammatory process, the mechanisms responsible for the injury to the bile duct epithelium are not understood. The presence in the serum of an antibody reacting with mitochondria has pointed to the possible importance of autoimmunity in pathogenesis, but, as this antibody is directed at an antigen located on the inner membrane of the mitochondrion2 and has no organ specificity, it seems unlikely that it could be effective in vivo in producing the localised liver lesion. It is more likely to be a consequence of the disease, perhaps being produced in response to an unusual microbial infection.3 Immune responses specifically directed at biliary antigens have recently been detected4 but the antigens involved are also found in other organs and it is again not clear what role these reactions have in pathogenesis. An unusual feature of the disease is the very high levels of circulating immune complexes, containing predominantly IgM antibody5
and it has been postulated that they could be involved in the bile duct injury.6
Received for publication 7 January 1980 Whatever the initial events, with progression of the disease the inflammatory infiltrate becomes more diffuse and cirrhosis eventually develops. In some cases the portal infiltrate breeches the limiting plate of the liver lobule and is associated with piecemeal necrosis of periportal hepatocytes,7 a feature which is more characteristic of chronic active hepatitis. Indeed, Doniach8 suggested that primary biliary cirrhosis and chronic active hepatitis may be at the opposite ends of a spectrum of autoimmune liver disease, sharing as they do several histological and immunlogical abnormalities. In chronic active hepatitis the periportal liver cell injury is associated with cellular and humoral immune responses to a liver-specific membrane lipoprotein (LSP) and there is strong circumstantial evidence that these may be responsible for the liver damage.9 Similar results have been reported in a small number of patients with primary biliary cirrhosis1011 but the test systems used have been cumbersome and relatively insensitive.
In this study we have used a newly developed, sensitive, and specific radioimmunoassay12 to measure the levels of antibody to LSP in the sera of 37 patients with primary biliary cirrhosis and have analysed the results in relation to the histological findings on liver biopsy. (Sigma) is then added and incubated for another hour at 4°C to facilitate precipitation of the antibody-1251-LSP complexes formed. Protein A, which is contained in the staphylococcal cell walls, avidly binds to the Fc region of IgG ;13 850 ,ul of a borate/EDTA buffer are then added to each tube to bring the final volume to 1.0 ml. After centrifugation at 20 000Xg for five minutes, 05 ml of the supernatant are removed and this and the reaction mixture (including the pellet) are each counted in a gamma counter. The percentage of the 1251-LSP bound by antibody in the pellet is calculated according to the formula: cpm lower 0.5 ml -cpm upper 0.5 ml X 100 cpm lower 0-5 ml + cpm upper 0-5 ml Blank samples not containing serum showed binding values of consistently less that 5%.
STATISTICAL METHODS
Bivariate linear regression analysis was used to calculate r values when percentage 1251-LSP binding was being compared with the results of tests in which an ordinal scale of measurement was available-for example, biochemical tests of liver function. As the histological findings were assessed on an interval scale, for comparisons using these results, r values were determined from the nonparametric Spearman correlation coefficient. (Figs 2 and 3) , 73% of those with stage IV changes having increased 1211-LSP binding and 45% moderate or severe piecemeal necrosis compared with 44% and 11% respectively in stage III and none of those in stages I or II. As stage IV is defined by the presence of cirrhosis, these differences also reflected a relationship between this histological feature and the presence of both anti-LSP antibodies and periportal liver cell change. The correlation between 1251-LSP binding and piecemeal necrosis, however, was also independent of the presence of cirrhosis, the extent of piecemeal necrosis in stage IV cases with increased LSP binding being significantly higher than in those at the same stage but with normal binding values (Fig. 3, P<0- 
